VENUNGOPAL, P.; BALAKRISHNAN, K.; SRIRAM, D. K.; GEORGE, M. INCLISIRAN (LEQVIO): A FIRST-IN-CLASS SMALL INTERFERING RNA THERAPEUTIC DRUG APPROVED BY FDA FOR TREATING PRIMARY HYPERCHOLESTEROLEMIA OR DYSLIPIDEMIA. Asian Journal of Pharmaceutical and Clinical Research, [S. l.], v. 15, n. 12, p. 42–46, 2022. DOI: 10.22159/ajpcr.2022.v15i12.46054. Disponível em: https://journals.innovareacademics.in/index.php/ajpcr/article/view/46054. Acesso em: 3 jul. 2024.